Scinai Immunotherapeutics Ltd.

US$0.44As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SCNIHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (59.62%)
Div yield —
ROE (26.10%)
Biotechnology
Beta (5Y) 2.26
PE TTM —
TSR TTM (96.85%)
Mkt cap US$0.251M
ROIC (63.83%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.44
(0.26%)
(29.08%)
Hold 9|0|2|8|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
29.97%
39.25%
21.94%
22.21%
Revenue$M
0.014
0.014
0.015
0.014
5.97%
3.27%
1.80%
0.25%
Peers (US$0.251M)
Cap (US$)
PE
1.580M
—
0.243M
—
Capital
TTM
5Y
10Y
Leveragex
0.823
1.382
1.248
EBIT/Intx
1.106
0.620
0.490
Own earn%
(42.20)
(194.15)
(180.68)
Sh yield%
28.03
44.16
43.75
Owners
Insiders/Inst%
6.42
57.52
Short interest%
4.16
SBC / revenue%
0.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
24–28
$1 testx
—
Incr. ROIC%
18